Cargando…

1171. Measles and Rubella Seroprevalence among HIV-infected and uninfected Children and Adults in Zambia

BACKGROUND: Despite the availability of safe and effective vaccines, measles and congenital rubella syndrome remain important causes of morbidity and mortality. HIV-infected individuals may be more vulnerable to measles because of poor immune responses to vaccination. Population-level estimates and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yangyupei, Mutembo, Simon, Carcelen, Andrea, Hayford, Kyla, Mwansa, Francis, Moss, William J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643959/ http://dx.doi.org/10.1093/ofid/ofab466.1364

Ejemplares similares

Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia
por: Carcelen, Andrea C., et al.
Publicado: (2021)

Measles immunity gaps among children and adolescents with HIV in Zambia despite high measles vaccination and antiretroviral therapy coverage
por: Mutembo, Simon, et al.
Publicado: (2023)

Leveraging a national biorepository in Zambia to assess measles and rubella immunity gaps across age and space
por: Carcelen, Andrea C., et al.
Publicado: (2022)

Integrating Blood Collection within Household Surveys: Lessons Learned from Nesting a Measles and Rubella Serological Survey within a Post-Campaign Coverage Evaluation Survey in Southern Province, Zambia
por: Mutembo, Simon, et al.
Publicado: (2018)

How much does it cost to measure immunity? A costing analysis of a measles and rubella serosurvey in southern Zambia
por: Carcelen, Andrea C., et al.
Publicado: (2020)

Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles–Rubella Supplementary Immunization Activity during the COVID-19 Pandemic
por: Yang, Yangyupei, et al.
Publicado: (2023)

Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey
por: Hayford, Kyla, et al.
Publicado: (2019)

Using geospatial models to map zero-dose children: factors associated with zero-dose vaccination status before and after a mass measles and rubella vaccination campaign in Southern province, Zambia
por: Arambepola, Rohan, et al.
Publicado: (2021)

An evaluation of the early impact of the COVID-19 pandemic on Zambia’s routine immunization program
por: Winter, Amy K., et al.
Publicado: (2023)

Acceptability of serosurveys in southern Zambia: data collector and caregiver perspectives
por: Carcelen, Andrea C., et al.
Publicado: (2023)

Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination
por: Winter, Amy K, et al.
Publicado: (2018)

1209. Seroprevalence of Measles, Mumps, and Rubella in Korean Healthcare Workers and Strategy for Vaccination
por: Ju Choo, Eun, et al.
Publicado: (2019)

P280: Seroprevalence of measles, rubella, mumps, and varicella among health care workers in Japan
por: Watanabe, T, et al.
Publicado: (2013)

Measles, rubella, mumps and chicken pox seroprevalence of health workers in a second level hospital
por: Guerrero Fernández de Alba, I, et al.
Publicado: (2022)

Purulent Bronchitis Complicating Measles and Rubella
Publicado: (1919)

Differential Diagnosis of Scarlet Fever, Measles and Rubella
Publicado: (1919)

Cord Blood Antibody Seroprevalance Against Diphtheria, Pertussis, Measles, Mumps and Rubella among Term Healthy Indian Newborns
por: James, Deepak, et al.
Publicado: (2017)

Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa
por: Richardson, Lauren Christine, et al.
Publicado: (2020)

1076. Gaps in Measles and Mumps Seroprevalence Among Cancer Patients
por: Marquis, Sara, et al.
Publicado: (2020)

1148. Long-term Persistence of Measles and Rubella Virus Neutralizing Antibody Levels among Adults with Three Doses of Measles-Mumps-Rubella Vaccine
por: Alonge, Oluwakemi, et al.
Publicado: (2023)

Measles, Mumps, Rubella serology in juvenile idiopathic arthritis
por: Heijstek, MW, et al.
Publicado: (2008)

2467. Timeliness of Childhood Vaccination With the Combination Measles–Mumps–Rubella–Varicella Vaccine vs. the Separate Measles–Mumps–Rubella and Varicella Vaccines in the United States
por: Wolfson, Lara, et al.
Publicado: (2018)

Diagnostic Accuracy of Dried Blood Spots Collected on HemaSpot HF Devices Compared to Venous Blood Specimens To Estimate Measles and Rubella Seroprevalence
por: Prosperi, Christine, et al.
Publicado: (2021)

Seroprevalence of Antibodies to Measles, Mumps, and Rubella among Thai Population: Evaluation of Measles/MMR Immunization Programme
por: Tharmaphornpilas, Piyanit, et al.
Publicado: (2009)

Two-dose measles–rubella vaccine schedule for measles–rubella elimination
por: John, T. Jacob
Publicado: (2023)

Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants
por: Cho, Hye-Kyung, et al.
Publicado: (2016)

A Nationwide Study on the Seroprevalence of Measles, Mumps, and Rubella in Iranian Children and Adolescents
por: Nokhodian, Zary, et al.
Publicado: (2022)

Predictors of Measles and Rubella Serostatus in Mother–Infant Pairs in Rural Nepal
por: Murray, Alastair, et al.
Publicado: (2017)

Seroprevalence and prevention of hepatitis B, measles and rubella among healthcare workers in Dili, Timor-Leste
por: Gusmao, Celia, et al.
Publicado: (2023)

Seroprevalence of measles and natural rubella antibodies among children in Bangui, Central African Republic
por: Manirakiza, Alexandre, et al.
Publicado: (2011)

Seroprevalence of Measles, Mumps, Rubella and Varicella Antibodies in the United States Population, 2009–2010
por: Lebo, Emmaculate J., et al.
Publicado: (2015)

Measles and rubella seroprevalence in a population of young adult blood donors, France 2013
por: Antona, D., et al.
Publicado: (2019)

Measles and rubella seroprevalence among adults in Georgia in 2015: helping guide the elimination efforts
por: Khetsuriani, N., et al.
Publicado: (2019)

Seroprevalence of Anti-Rubella and Anti-Measles IgG Antibodies in Pregnant Women in Shiraz, Southern Iran: Outcomes of a Nationwide Measles-Rubella Mass Vaccination Campaign
por: Honarvar, Behnam, et al.
Publicado: (2013)

COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa
por: Carcelen, Andrea C., et al.
Publicado: (2021)

Seroprevalence of measles, mumps, rubella, varicella–zoster and hepatitis A–C in Emirati medical students
por: Sheek-Hussein, Mohamud, et al.
Publicado: (2012)

Seroprevalence of measles, mumps, rubella, and varicella-zoster antibodies in new female nurses in the Republic of Korea
por: Yoo, Yeongjae, et al.
Publicado: (2021)

Optimization and Stability Testing of Four Commercially Available Dried Blood Spot Devices for Estimating Measles and Rubella IgG Antibodies
por: Kaduskar, Ojas, et al.
Publicado: (2021)

2771. Seroprotection against Measles, Rubella, Tetanus, and Diphtheria Among Children in Haiti—2017
por: Minta, Anna A, et al.
Publicado: (2019)

1171. Lower Mortality with Adjuvant Corticosteroid Therapy in non-HIV Infected Patients with pneumocystis jirovecii pneumonia: A Single US Cohort Study and a Proposed Novel Mechanism of Corticosteroids
por: Mundo, William, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_csip8dsel41je5ruu8nkcdtfai